Q: I am interested in ABCL based on my belief that the technology has many potential applications for many years to come. However, there are a few things I am wondering about. The stock has been on a steady decline for months, I presume due to the release of restricted shares and the fear that revenues will decline post-covid.
I expected that ABCLs Covid treatment would gain more acceptance and use than it did...esp. in places like India that were so desperate. But for some reason it just sat on shelves across Canada, even though it was approved federally, and by the FDA in the US. This makes me wonder about ABCLs marketing and business development. I know they have some partnerships with large partners, but I find it hard to quantify those in monetary terms.
What are your thoughts on these concerns? Do you see the continued decline as a sign of problems, or is it more of a buying opportunity for long term investors, and what is your confidence level?
Thanks,
I expected that ABCLs Covid treatment would gain more acceptance and use than it did...esp. in places like India that were so desperate. But for some reason it just sat on shelves across Canada, even though it was approved federally, and by the FDA in the US. This makes me wonder about ABCLs marketing and business development. I know they have some partnerships with large partners, but I find it hard to quantify those in monetary terms.
What are your thoughts on these concerns? Do you see the continued decline as a sign of problems, or is it more of a buying opportunity for long term investors, and what is your confidence level?
Thanks,